Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2008
07/30/2008CN101229310A Chinese traditional medicine compounds for treating acute and chronic enteritis, colonitis and preparing method thereof
07/30/2008CN101229308A Quality control method of liu-wei tonic tablets dual-wavelength fingerprint chromatogram
07/30/2008CN101229303A Technology of preparing granular formulation for treating chilly type gastritis
07/30/2008CN101229291A Chinese traditional medicine immunoregulation prescription for treating virus hepatitis and method thereof
07/30/2008CN101229280A Chinese traditional medicine preparation for treating intestinal obstruction
07/30/2008CN101229278A Medicine compounds for treating rectum cancer and gastric cancer
07/30/2008CN101229275A Compounds used for tonifying the kidney, nourishing the liver and preparing method thereof
07/30/2008CN101229268A Retinervus-smoothing regeneration ointment
07/30/2008CN101229256A Medicine compounds for treating customary constipation and preparing method thereof
07/30/2008CN101229253A Compounds for control appetite primness and preparing method thereof
07/30/2008CN101229251A Chinese traditional medicine for treating diarrhoea, bacillary dysentery and colonitis
07/30/2008CN101229248A Quality standard and test method of hoove pill and preparation threrewith
07/30/2008CN101229235A Process for preparing corydalis saxicola bunting total alkali
07/30/2008CN101229233A Chinese traditional medicine preparation for antiatheroscloresis and liver-protection, and preparingng method thereof
07/30/2008CN101229225A Salvia miltiorrhiza total phenolic acid gastric stasis preparation
07/30/2008CN101229223A Applications of fructus psoraleae extractive on preparing antitumor medicines
07/30/2008CN101229214A Medical applications of stringy stonecrop ethamol soluble extractive
07/30/2008CN101229213A Rhodiola rosea compound healthy product
07/30/2008CN101229209A Process for preparing silybin oil lipidosome and applications thereof
07/30/2008CN101229206A Propolis gen-seng buccal tablets and preparing method thereof
07/30/2008CN101229203A Valid target of common peganum seed, preparing method and uses of dehydrogenization telepathine monomer
07/30/2008CN101229196A Microecologic preventing grice diarrhoea and preparing method thereof
07/30/2008CN101229194A Medicine for treating gall-stone, nephrolith and lithangiuria, preparing method thereof
07/30/2008CN101229187A Simethicone emulsion and preparing method thereof
07/30/2008CN101229186A Hyaluronic acid oligosaccharide fractions and drugs containing the same
07/30/2008CN101229183A Ribonucleic acid retrogradation snippet compound and applications thereof
07/30/2008CN101229178A Compound medicine compounds containing adefovir dipivoxil, preparing method and uses thereof
07/30/2008CN101229168A Immunity excitant containing selenium
07/30/2008CN101229162A Freeze-dried powder injection containing dextrogyrate rabeprazole and salts thereof, preparing technology thereof
07/30/2008CN101229159A Medicine for treating infectious diarrhea and peptic ulcer, preparing method and applications thereof
07/30/2008CN101229147A Use of N-4-hydroxyphenyl retinamide on preparing anti-hepatic fibrosis medicine
07/30/2008CN101229142A Lansoprazole enteric coated tablet and preparing method thereof
07/30/2008CN101229138A Pantoprazole sodium freeze-dried powder injection and preparing method thereof
07/30/2008CN101229136A Lansoprazole freeze-dried powder for injection and preparing method thereof
07/30/2008CN101229133A Omeprazole sodium freeze-dried powder injection and preparing method thereof
07/30/2008CN101229125A Microemulsion injection containing injectio natarii norcantharidatis
07/30/2008CN101228945A Ginger noodle and producing method thereof
07/30/2008CN101228936A Low calorific value bean paste and preparing method thereof
07/30/2008CN101228915A Coral calcium tablet
07/30/2008CN100406562C Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
07/30/2008CN100406558C Method for preparing recombinant aprotinin
07/30/2008CN100406454C Pyrazole compounds useful as protein kinase inhibitors.
07/30/2008CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors
07/30/2008CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these
07/30/2008CN100406065C Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use
07/30/2008CN100406064C Formulation for treating disease infected by helicobacter pylori
07/30/2008CN100406059C Novel use of parathyroid hormone
07/30/2008CN100406050C A Chinese traditional medicinal preparation for improving sub-health disease
07/30/2008CN100406038C Method for preparing external-use Chinese medicine for treating ulcerative stomatitis
07/30/2008CN100406032C Oral ulcer powder
07/30/2008CN100406030C Chinese medicinal preparation for treating ulcerative stomatitis and method for preparing same
07/30/2008CN100406028C Chinese-medicinal preparation for treating white mouth and yellow mouth
07/30/2008CN100406027C Combination of Chinese traditional medicine for treating disease of liver and preparation method
07/30/2008CN100406026C Medicine for treating chronic gastritis and gastric carcinoma, and its preparing method
07/30/2008CN100406014C Famciclovir slow-releasing capsule for anti-virus treatment and its producing method
07/30/2008CN100406009C Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
07/30/2008CN100405920C Dried orange peel health-care tea
07/29/2008US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
07/29/2008US7405058 Thymic stromal lymphopoietin (TSLP); nucleic acid encoding polypeptide of given sequence; use in peptide fragmentation studies and molecular weight measurements
07/29/2008US7404960 Multivalent vaccine composition having increased stability of capsular polysaccharide
07/29/2008US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders
07/29/2008CA2432222C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2432132C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
07/29/2008CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
07/29/2008CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
07/29/2008CA2348742C Carbocyclic potassium channel inhibitors
07/29/2008CA2344672C Expandable gastroretentive therapy system having a prolonged gastric residence time
07/29/2008CA2333656C A novel vla-4 inhibitor: omepupa-v
07/29/2008CA2218702C Fatty acid esters as bioactive compounds
07/29/2008CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
07/29/2008CA2147882C Bifidobacterium growth promotant
07/24/2008WO2008089027A1 Compounds for the treatment of hepatitis c
07/24/2008WO2008088524A2 Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor
07/24/2008WO2008088047A1 Method for glycosylation of flavonoid
07/24/2008WO2008088008A1 Prophylactic and/or therapeutic agent for functional dyspepsia
07/24/2008WO2008088006A1 Ap2 inhibitor
07/24/2008WO2008087862A1 Agent against periodontal disease
07/24/2008WO2008087461A2 Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis
07/24/2008WO2008087081A1 Process for solvent removal from omeprazole salts
07/24/2008WO2008086750A1 Mixed fermentation method of callicarpa dichotoma (lour.) k. koch and edible fungus, prepared products via the method and uses thereof
07/24/2008WO2008086729A1 New dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis
07/24/2008WO2008068408A3 Oral hygiene composition and its use in the treatment of halitosis
07/24/2008WO2008067257A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
07/24/2008WO2008060764A3 Topical therapies for oral mucositis and other conditions
07/24/2008WO2008033328A3 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
07/24/2008WO2008021375A3 Modulators of muscarinic receptors
07/24/2008US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors
07/24/2008US20080177042 Leucine-based motif and clostridial neurotoxins
07/24/2008US20080177041 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders
07/24/2008US20080177037 Leucine-based motif and clostridial neurotoxins
07/24/2008US20080176961 Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain
07/24/2008US20080176959 Biodegradable polyphosphates complex for controlled release of bioactive substances and related methods
07/24/2008US20080176951 Methods of treating gastrointestinary and genitourinary pain disorders
07/24/2008US20080176924 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
07/24/2008US20080176918 Adrenergic stimulant; 4-[1-(2,3-dimethyl-phenyl)-ethyl]-1,3-dihydro-imidazole-2-thione; hypertension, glaucoma, spasticity, pain, attention deficit disorder
07/24/2008US20080176916 A-amino-n-hydroxy-acetamide derivatives
07/24/2008US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders
07/24/2008US20080176895 Gastrointestinal disorders; selectivity, potency, pharmacokinetics, duration of action; minimal side effects
07/24/2008US20080176867 e.g., N-[[5-(4-bromophenyl)-4-(2,4-dichlorophenyl)pyrimidin-2-yl]methyl]-3-(trifluoromethyl)benzenesulfonamide; cannabinoid receptor modulator; metabolic and gastrointenstinal disorders, antidiabetic, antiinflammatory, analgesic agent; neurodegenerative diseases